NEU 1.16% $18.80 neuren pharmaceuticals limited

Acadia, page-484

  1. 2,759 Posts.
    lightbulb Created with Sketch. 476
    Missing a sales target is one thing. NEU royalty receipts are all profit and largely still intact with an Acadia modest sales target miss.
    Acadia guidance for net sales in 2024 is still intact. A first sales milestone payment of US$50 million to Neuren is expected to be earned for 2024 on Daybue sales reaching US$250M.
    Things could be much worse.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$18.80
Change
-0.220(1.16%)
Mkt cap ! $2.401B
Open High Low Value Volume
$18.96 $19.06 $18.80 $626.7K 33.20K

Buyers (Bids)

No. Vol. Price($)
2 59 $18.80
 

Sellers (Offers)

Price($) Vol. No.
$18.83 45 4
View Market Depth
Last trade - 10.51am 12/06/2024 (20 minute delay) ?
Last
$18.85
  Change
-0.220 ( 0.18 %)
Open High Low Volume
$18.95 $19.02 $18.80 9586
Last updated 11.12am 12/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.